xellia pharmacueticals usa llc

Activity value 61 india Supplier,Last transaction date: 2024-02-19

Overview
Export data
Partners
HS Codes
Products
Areas
Ports

Trade trend analysis

Mon | Year

Number of Transactions Quantity Weight

The above chart presents the market trend analysis for xellia pharmacueticals usa llc from 2023 to 2024. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2024, the company has completed 3 transactions, with a transaction quantity of 6 and a transaction weight of 0.

Year Transactions Quantity Weight
2023 0 0 0
2024 3 6 0

Bill of lading data

< 1/4 >

Trade date 2024/02/19 B/L No. 8354503
Suppliers xellia pharmacueticals usa llc Buyers gland pharma
POLs —— PODs hyderabad air
Supply area India Purchas area India
Weight —— Amount 20
Hs code 29339990 Product tags daptomycin
Product description DAPTOMYCIN (FOC) 29 3 Expand

Trade date 2024/02/12 B/L No. 6034600
Suppliers xellia pharmacueticals usa llc Buyers gland pharma
POLs —— PODs hyderabad air
Supply area India Purchas area India
Weight —— Amount 60
Hs code 29339990 Product tags daptomycin
Product description DAPTOMYCIN (FOC) 29 2 Expand

Trade date 2024/01/18 B/L No. 6655876
Suppliers xellia pharmacueticals usa llc Buyers gland pharma
POLs —— PODs hyderabad air cargo
Supply area India Purchas area India
Weight —— Amount 10
Hs code 29339990 Product tags daptomycin
Product description DAPTOMYCIN (FOC) Expand

Trade date 2021/12/29 B/L No. c97hmxfy0920g
Suppliers xellia pharmacueticals usa llc Buyers gland pharma
POLs —— PODs hyderabad
Supply area India Purchas area India
Weight —— Amount 100.81
Hs code 29339990 Product tags daptomycin
Product description DAPTOMYCIN Expand

Partners

Total 1

Rank Company Transactions Per Detail
1 gland pharma indiabuyer,they trade on 2024-02-19 4 100.00% >

Products

Total 1

Products Transactions Per Detail
daptomycin
3 100% >

Hscode rank

Total 0

HSCode Name Transactions Per Detail
HS 29339990 3 100% >

xellia pharmacueticals usa llc is india Supplier, and primarily engages in the import and export business of products such as daptomycin. According to the 52wmb.com global trade database, as of 2024-02-19, the company has completed 4 international trades, The core products include HS29339990 etc, and its main trading partners are gland pharma. These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing. They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development. They provide reliable support for cross-border trade decision-making.

The trade data displayed on xellia pharmacueticals usa llc is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis. We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.

Reference contact info

Email Hunting Tool

Employee emails